Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of metformin on Anti-Müllerian hormone levels in obese women with PCOS
IRCT201107317165N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of metformin in polycystic ovary syndrome (PCOS) and obesity, sponsored by Tehran University of Medical Sciences. Primary endpoint: Change in Anti-Müllerian hormone (AMH) level. Started Aug 2011; status: completed.
02
Drugs
metformin
03
Conditions
polycystic ovary syndrome (PCOS)obesity
Beyond the preview
Go deeper on IRCT201107317165N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201107317165N1.